We are live on ! Find out more
OPK icon

Opko Health

230 hedge funds and large institutions have $376M invested in Opko Health in 2023 Q2 according to their latest regulatory filings, with 30 funds opening new positions, 56 increasing their positions, 60 reducing their positions, and 25 closing their positions.

New
Increased
Maintained
Reduced
Closed

78% more call options, than puts

Call options by funds: $5.14M | Put options by funds: $2.88M

45% more capital invested

Capital invested by funds: $259M → $376M (+$117M)

20% more first-time investments, than exits

New positions opened: 30 | Existing positions closed: 25

1% more funds holding

Funds holding: 227230 (+3)

0% more funds holding in top 10

Funds holding in top 10: 11 (0)

0.55% less ownership

Funds ownership: 23%22.46% (-0.55%)

7% less repeat investments, than reductions

Existing positions increased: 56 | Existing positions reduced: 60

Holders
230
Holders Change
+3
Holders Change %
+1.32%
% of All Funds
3.61%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.02%
New
30
Increased
56
Reduced
60
Closed
25
Calls
$5.14M
Puts
$2.88M
Net Calls
+$2.25M
Net Calls Change
+$2.42M
Name Holding Trade Value Shares
Change
Change in
Stake
American Century Companies
76
American Century Companies
Missouri
$294K +$58K +37,092 +38%
Cambridge Investment Research Advisors
77
Cambridge Investment Research Advisors
Iowa
$289K +$2.11K +1,351 +1%
WSTAM
78
Wilbanks Smith & Thomas Asset Management
Virginia
$285K
New York State Common Retirement Fund
79
New York State Common Retirement Fund
New York
$278K -$107K -68,500 -35%
ASRS
80
Arizona State Retirement System
Arizona
$259K -$40.9K -26,166 -18%
CAG
81
Csenge Advisory Group
Florida
$254K
HWP
82
Highline Wealth Partners
California
$253K +$15.6K +10,000 +9%
William Blair & Company
83
William Blair & Company
Illinois
$238K +$172K +109,787 New
Ameriprise
84
Ameriprise
Minnesota
$237K +$626 +400 +0.4%
GCM
85
Graham Capital Management
Connecticut
$236K -$788K -503,746 -82%
BNP Paribas Financial Markets
86
BNP Paribas Financial Markets
France
$228K -$142K -90,955 -46%
ICM
87
Intrepid Capital Management
Florida
$217K
QT
88
Quantbot Technologies
New York
$217K -$18.1K -11,590 -10%
Creative Planning
89
Creative Planning
Kansas
$214K -$2.12K -1,355 -1%
Handelsbanken Fonder
90
Handelsbanken Fonder
Sweden
$187K -$24.2K -15,500 -15%
HCM
91
Hollencrest Capital Management
California
$182K
RFWA
92
RPg Family Wealth Advisory
Massachusetts
$174K +$126K +80,330 New
SG Americas Securities
93
SG Americas Securities
New York
$168K -$166K -106,359 -58%
Franklin Resources
94
Franklin Resources
California
$168K +$121K +77,419 New
TMC
95
Trellus Management Company
Florida
$161K +$116K +74,388 New
BWA
96
BDO Wealth Advisors
Florida
$152K
PAMS
97
Pictet Asset Management (Switzerland)
Switzerland
$142K
SAM
98
Shell Asset Management
Netherlands
$140K -$579 -370 -0.6%
Public Employees Retirement Association of Colorado
99
Public Employees Retirement Association of Colorado
Colorado
$133K
Amundi
100
Amundi
France
$129K

OPK Hedge Fund Activity: Q2 2023 in Review

230 of the 6,369 institutional investors tracked by Wall St. Rank reported a position in Opko Health (OPK) for Q2 2023, worth a combined $376M — up 45% from $259M a quarter earlier.

Buyers outnumbered sellers: 30 funds opened new OPK positions and 25 closed out — a net gain of 5 holders — while 56 added to existing stakes and 60 trimmed.

The largest buyer was Point72 Asset Management, adding an estimated $2.36M. The largest seller was Dimensional Fund Advisors, cutting an estimated $4.89M.

  • 230 institutional investors held Opko Health (OPK) as of Q2 2023, up from 227 in Q1 2023.
  • Funds reported $376M of Opko Health stock for Q2 2023, up 45% quarter-over-quarter.
  • 30 funds opened new Opko Health positions in Q2 2023 and 25 closed out, a net change of +5 holders.
  • The largest Opko Health buyer in Q2 2023 was Point72 Asset Management, an estimated $2.36M added.
  • The largest Opko Health seller in Q2 2023 was Dimensional Fund Advisors, an estimated $4.89M sold.

Based on aggregated 13F filings for Q2 2023.